Generex Biotechnology Corporation today announced a reverse stock split of its shares of common stock at a ratio of 1-for-1000. As of the open of the market on March 14, 2017, the Company’s common stock will begin trading on a split …
Generex Biotechnology (GNBT) just announced a few minutes ago that results from ... Generex Biotechnology has since broken out of its narrow trading range and is now up 0.11 at $0.43. The stock is attempting to rebound from the lows of …
Common Stock Issuance is the amount of money the company generates when a company initially sold its common stock and preferred on the open market to investors. Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash …
Generex Biotechnology Corporation (OTCPink:GNBT) is pleased to announce that on January 16 ... for $225,000,000 in a combination of cash and shares of Generex common stock. Dr. Yutaka Niihara, MD, MPH, Emmaus’ Chief Executive …
The further back you go in time, the worse the overall picture becomes for Generex Biotechnology Corp (OTC:GNBT, GNBT message board) stock. Used to trade on the NASDAQ, used to trade above $15 per share. All in the past now, ...
while Generex will formulate and fill Generex Oral-lyn for marketing and distribution by SciGen in the territory. More details... Stock Symbols: (ASX: SIE) (NSDQ: GNBT) Sorry... this feature or article is only available to subscribers.
GNBT) have lost a whopping 74% so far this year, sending shares to a 52-week low of under 4 cents. The company shed nearly 10% in one day late last month after announcing a secondary stock offering. For more big news in the sector, …
GNBT: Summary for GENEREX BIOTECH CORP- Yahoo! Finance View the basic GNBT stock chart on Yahoo! Finance. Change the date range, chart type and compare GENEREX BIOTECH CORP against other companies. Wave Systems …